Ophthalmology · Miami, FL
NPI
1497756365
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1097 S Lejeune Rd
Miami, FL, 33145
Phone (305) 442-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
194 services
Medicare patients, 2024
87
Average age 76
Drug cost, 2024
$5.5M
15,845 prescriptions
Company payments, 2025
$11K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arnulfo V Mansur was code 99214 (office e&m - established), 52 times for 49 patients. In total Arnulfo V Mansur billed 194 services in 24 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 52 | 49 | $88.99 | $4,628 |
| 92133 Computerized Ophthalmic Imaging | Office | 21 | 21 | $24.36 | $512 |
| 92083 Vision, Hearing, and Speech Services | Office | 17 | 13 | $28.79 | $489 |
| 92285 Standard X-ray | Office | 15 | 15 | $17.35 | $260 |
| 92014 Ophthalmological E&M | Office | 15 | 14 | $88.24 | $1,324 |
| 92082 Vision, Hearing, and Speech Services | Office | 14 | 11 | $21.33 | $299 |
| 92004 Ophthalmological E&M | Office | 14 | 14 | $113.69 | $1,592 |
| 92020 Ophthalmological E&M | Office | 12 | 12 | $18.38 | $221 |
By year: 2022 $21K for 233 services; 2023 $13K for 181 services; 2024 $16K for 194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arnulfo V Mansur prescribed most often to Medicare patients was Cequa (Cyclosporine), with 3,588 prescriptions and refills. In total Arnulfo V Mansur wrote 15,845 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cequa Cyclosporine | 3,588 | 6,606 | 1,268 | $3.7M |
| Erythromycin Erythromycin Base | 1,947 | 1,951 | 1,217 | $15K |
| Lumigan Bimatoprost | 1,851 | 2,538 | 494 | $672K |
| Latanoprost Generic | 1,008 | 1,322 | 312 | $5,194 |
| Prednisolone Acetate Generic | 840 | 954 | 650 | $24K |
| Cyclosporine Generic | 804 | 813 | 296 | $51K |
| Doxycycline Hyclate Generic | 636 | 636 | 562 | $4,068 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 497 | 543 | 132 | $189K |
| Moxifloxacin Moxifloxacin Hcl | 430 | 430 | 361 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 418 | 692 | 147 | $4,376 |
| Brimonidine Tartrate Generic | 369 | 512 | 121 | $7,472 |
| Rhopressa Netarsudil Mesylate | 303 | 364 | 88 | $119K |
| Doxycycline Monohydrate Generic | 287 | 287 | 258 | $1,262 |
| Simbrinza Brinzolamide/Brimonidine Tart | 251 | 277 | 76 | $53K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 231 | 231 | 194 | $2,158 |
Brand drugs: 10,043 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arnulfo V Mansur $11K ($11K in general payments such as food, travel and fees) from 7 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $7,265.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $7,265 |
| Abbvie Inc. ABBV | 31 | $2,429 |
| Alcon Vision LLC ALC | 20 | $609 |
| Mallinckrodt Hospital Products Inc. | 17 | $519 |
| Bausch & Lomb Americas Inc. BLCO | 19 | $390 |
| Harrow Eye, LLC | 4 | $133 |
| Amgen Inc. AMGN | 4 | $82.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.